Study to Evaluate Effectiveness and Safety in Subjects With Moderate to Severe Psoriasis
Public ClinicalTrials.gov record NCT02931838. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Phase 2 Study to Evaluate the Clinical Efficacy and Safety of BMS-986165 in Subjects With Moderate to Severe Psoriasis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A Study to evaluate efficacy and safety in subjects with moderate to severe Psoriasis treated with BMS-986165
Study identification
- NCT ID
- NCT02931838
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 268 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 14, 2016
- Primary completion
- Nov 15, 2017
- Completion
- Nov 15, 2017
- Last update posted
- Nov 26, 2020
2016 – 2017
United States locations
- U.S. sites
- 16
- U.S. states
- 11
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of California Irvine | Irvine | California | 92697 | — |
| University of California San Diego | San Diego | California | 92122 | — |
| Renstar Medical Research | Ocala | Florida | 34471 | — |
| Dermatologic Surgery Specialists, PC | Macon | Georgia | 31217 | — |
| PMG Research of Christie Clinic, LLC | Champaign | Illinois | 61820 | — |
| NorthShore University Health System | Skokie | Illinois | 60077 | — |
| Dawes Fretzin Clinical Research Group, LLC | Indianapolis | Indiana | 46256 | — |
| Dartmouth-Hitchcock Medical Center-Norris Cotton Cancer Center | Lebanon | New Hampshire | 03756 | — |
| Piedmont Plastic Surgery & Dermatology - Charlotte/Blakeney Location | Charlotte | North Carolina | 28277 | — |
| PMG Research of Rocky Mount, LLC | Rocky Mount | North Carolina | 27804 | — |
| PMG Research of Wilmington, PLC | Wilmington | North Carolina | 28401 | — |
| Central Sooner Research | Norman | Oklahoma | 73071 | — |
| Health Concepts | Rapid City | South Dakota | 57702 | — |
| Rivergate Dermatology Clinical Research Center, Pllc | Goodlettsville | Tennessee | 37072 | — |
| Local Institution | Knoxville | Tennessee | 37920 | — |
| Austin Dermatology Associates | Austin | Texas | 78705 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 60 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02931838, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 26, 2020 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02931838 live on ClinicalTrials.gov.